← Back to Search

Repetitive Transcranial Magnetic Stimulation

Pilot arm for Generalized Anxiety Disorder

N/A

Waitlist Available

Led By Nicholas L Balderston

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre and post stimulation

Awards & highlights

Study Summary

This trial will study if a certain kind of brain stimulation is safe and tolerable for people with anxiety, and if it has any effect on their symptoms.

Eligible Conditions

Generalized Anxiety Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post stimulation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post stimulation

This trial's timeline: 3 weeks for screening, Varies for treatment, and post stimulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Anxiety Potentiated Startle (APS)

Visual Short Term Memory Performance (VSTM)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Pilot armExperimental Treatment1 Intervention

Aims 1 and 2 of this project will be tested using a within-subjects design where anxiety patients will receive a 5-day course of accelerated 1 Hz rTMS (8x session x 600 pulses/session) to the right IPS.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,880,083 Total Patients Enrolled

5 Trials studying Generalized Anxiety Disorder

420 Patients Enrolled for Generalized Anxiety Disorder

Nicholas L BalderstonPrincipal InvestigatorUniversity of Pennsylvania

1 Previous Clinical Trials

200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals below the age of 50 able to partake in this experiment?

"As stipulated in the criteria for inclusion, only individuals between 18 and 50 years of age can be enrolled in this clinical trial."

Answered by AI

What criteria must potential participants fulfill to be considered for this research endeavor?

"This clinical trial is looking to enroll 10 adults aged 18-50 with a DSM-V classified anxiety disorder, who are right handed and have the capacity for informed consent."

Answered by AI

Is this research endeavor actively seeking participants?

"Affirmative. Clinicaltrials.gov data shows that this trial, which initially was listed on May 19th 2022, is currently recruiting participants. 10 individuals are required to be enrolled at 1 clinical site."

Answered by AI

How many participants are being allowed to join this research endeavor?

"Affirmative. The information hosted on clinicaltrials.gov indicates that the recruitment process for this trial is ongoing and began on May 19th 2022. As of June 13th, only 10 patients have been admitted from 1 medical centre."

Answered by AI

Recent research and studies

Translational PsychiatryJournal

Low-frequency Parietal Repetitive Transcranial Magnetic Stimulation Reduces Fear and Anxiety

Balderston, Nicholas L., Emily M. Beydler, Madeline Goodwin, Zhi-De Deng, Thomas Radman, Bruce Luber, Sarah H. Lisanby, Monique Ernst, and Christian Grillon. 2020. “Low-frequency Parietal Repetitive Transcranial Magnetic Stimulation Reduces Fear and Anxiety”. Translational Psychiatry. Springer Science and Business Media LLC. doi:10.1038/s41398-020-0751-8.

clinicaltrials.govStudy

rTMS Pilot for Anxiety

2022. "rTMS Pilot for Anxiety". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05306977.